Umoja wa Ulaya - Kidenmaki - EMA (European Medicines Agency)

abbvie deutschland gmbh co. kg - glecaprevir, pibrentasvir - hepatitis c kronisk - antivirale midler til systemisk anvendelse - maviret is indicated for the treatment of chronic hepatitis c virus (hcv) infection in adults and children aged 3 years and older. maviret coated granules is indicated for the treatment of chronic hepatitis c virus (hcv) infection in children 3 years and older.

Denmaki - Kidenmaki - Lægemiddelstyrelsen (Danish Medicines Agency)

krka sverige ab - fluconazol - kapsler, hårde - 150 mg

Denmaki - Kidenmaki - Lægemiddelstyrelsen (Danish Medicines Agency)

krka sverige ab - fluconazol - kapsler, hårde - 200 mg

Denmaki - Kidenmaki - Lægemiddelstyrelsen (Danish Medicines Agency)

pfizer aps - fluconazol - kapsler, hårde - 150 mg

Denmaki - Kidenmaki - Lægemiddelstyrelsen (Danish Medicines Agency)

pfizer aps - fluconazol - kapsler, hårde - 200 mg

Denmaki - Kidenmaki - Lægemiddelstyrelsen (Danish Medicines Agency)

europharma.dk aps - fluconazol - pulver til oral suspension - 10 mg/ml

Umoja wa Ulaya - Kidenmaki - EMA (European Medicines Agency)

amryt pharmaceuticals dac - lomitapide - hyperkolesterolæmi - lipid modificerende midler - lojuxta er indiceret som et supplement til en low‑fat kost og andre lipid‑lowering lægemidler med eller uden lav density lipoprotein (ldl) aferese hos voksne patienter med homozygot familiær hyperkolesterolæmi (hofh). genetiske bekræftelse af hofh skal indhentes, når det er muligt. andre former for primær hyperlipoproteinaemia og sekundære årsager til hypercholesterolaemia e. nefrotisk syndrom, hypothyroidisme) skal udelukkes,.

Denmaki - Kidenmaki - Lægemiddelstyrelsen (Danish Medicines Agency)

primex pharmaceuticals oy - midazolam - oral opløsning, enkeltdosisbeholder - 2 mg/ml

Umoja wa Ulaya - Kidenmaki - EMA (European Medicines Agency)

merck sharp & dohme b.v. - doravirine, lamivudin, er tenofovir disoproxil fumarate - hiv infektioner - antivirale midler til behandling af hiv-infektioner, kombinationer - delstrigo er indiceret til behandling af voksne, som er smittet med hiv-1 uden tidligere eller nuværende bevis for modstand, nnrti klasse, lamivudin, eller tenofovir. delstrigo is also indicated for the treatment of adolescents aged 12 years and older weighing at least 35 kg who are infected with hiv-1 without past or present evidence of resistance to the nnrti class, lamivudine, or tenofovir and who have experienced toxicities which preclude the use of other regimens that do not contain tenofovir disoproxil.

Umoja wa Ulaya - Kidenmaki - EMA (European Medicines Agency)

merck sharp & dohme b.v. - doravirine - hiv infektioner - antivirale midler til systemisk anvendelse - pifeltro is indicated, in combination with other antiretroviral medicinal products, for the treatment of adults, and adolescents aged 12 years and older weighing at least 35 kg infected with hiv 1 without past or present evidence of resistance to the nnrti class.